DISEASE INDICATIONS: Chronic Obstructive Pulmonary Disease, Asthma
MANUFACTURER: GlaxoSmithKline
USAGE: Oral
MEDICINE APPROVED BY:
European Medical Agency (EMA)
Food and Drug Administration (FDA)
Pharmaceuticals and Medical Devices Agency (PMDA)
It is used for the management of chronic obstructive pulmonary disease (COPD), a chronic respiratory condition characterized by breathing difficulties, coughing, and wheezing. This medication is designed to provide comprehensive treatment for COPD by addressing various aspects of the disease.
